Surgery – Container for blood or body treating material – or means used... – Bag type
Reexamination Certificate
2005-09-07
2011-11-08
Deak, Leslie (Department: 3761)
Surgery
Container for blood or body treating material, or means used...
Bag type
C604S004010, C604S006010, C604S006030, C604S006070, C604S006150, C604S403000, C604S406000, C604S408000, C604S416000, C435S325000, C435S366000, C435S372000, C435S374000
Reexamination Certificate
active
08052667
ABSTRACT:
The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.
REFERENCES:
patent: 4344936 (1982-08-01), Soslau
patent: 4407660 (1983-10-01), Nevens et al.
patent: 4432750 (1984-02-01), Estep et al.
patent: 4467588 (1984-08-01), Carveth
patent: 4610684 (1986-09-01), Knox et al.
patent: 4701267 (1987-10-01), Watanabe et al.
patent: 4915848 (1990-04-01), Carmen et al.
patent: 4994039 (1991-02-01), Mattson
patent: 5344561 (1994-09-01), Pall et al.
patent: 5676941 (1997-10-01), Souza
patent: 5876676 (1999-03-01), Stossel et al.
patent: 5910252 (1999-06-01), Truitt et al.
patent: 5919614 (1999-07-01), Livesey et al.
patent: 6743575 (2004-06-01), Wiggins et al.
patent: 7018985 (2006-03-01), Boyer et al.
patent: 7037428 (2006-05-01), Robinson et al.
patent: 7645609 (2010-01-01), Follstad
patent: 2002/0009705 (2002-01-01), Lucas et al.
patent: 2002/0182581 (2002-12-01), Cook et al.
patent: 2002/0193350 (2002-12-01), Ellington et al.
patent: 2003/0104349 (2003-06-01), Bischof et al.
patent: 2003/0176352 (2003-09-01), Min et al.
patent: 2004/0137557 (2004-07-01), DeFrees et al.
patent: 2004/0185036 (2004-09-01), Stossel et al.
patent: 2010/0160212 (2010-06-01), Sheffer et al.
patent: WO 98/41087 (1998-09-01), None
patent: WO 02/16381 (2002-02-01), None
patent: WO 2004/043381 (2004-05-01), None
Online encyclopedia article “Blood Bank” accessed Jan. 31, 2011. http://en.wikipedia.org/wiki/Blood—bank.
International Search Report (PCT/US06/40579); Date of Mailing: May 10, 2007; 1 page.
Hoffmeister et al.; “Glycosylation Restores Survival of Chilled Blood Platelets;” Science; Sep. 12, 2003; vol. 301; pp. 1531-1534.
Supplementary European Search Report—EP 06836356 dated Jan. 27, 2010.
Raju T Shantha et al., “Glycoengineering of Therapeutic Glycoproteins : In Vitro Galactosylation and Sialylation of Glycoproteins with Terminal N-Acetylglucosamine and Galactose Residues”, Biochemistry, American Chemical Society, Easton, PA.; US, 2001, vol. 40, pp. 8868-8876.
Hoffmeister Karin M et al., “The Clearance Mechanism of Chilled Blood Platelets”, Cell, 2003, vol. 112, pp. 87-97.
Database Biosis [Online] Biosciences Information Service, Philadelphia, PA, US, Nov. 16, 2003, Hoffmeister Karin M et al., “Galactosylation Enables Prolonged Survival of Chilled Platelets in Mice”, Database accession No. PREV200400172516.
Database CA (Online) Chemical Abstracts Service, Columbus, Ohio, US; Cui, Yun et al: “Study on the effect of UDP-Gal on platelets stored at low temperature by 51Cr tracing” XP002471055 retrived from STN Database accession No. 2006:171349.
Database CA (Online) Chemical Abstracts Service, Columbus, Ohio, US; Mester, L. et al: “Role of sialic acid in the mechanism of platelet aggregation.” XP002471056 retrieved from STN Database accession No. 1973: 544679.
EPO Search Report for 05811897 dated Mar. 17, 2008, 8 pages.
PCT Search Report (PCT/US2005/037241): Date of Mailing May 1, 2006; 5 pages.
Aas & Gardener, “Survival of Blood Platelets with Chromium 51”, J Clin. Invest., Sep. 1958, vol. 37, pp. 1257-1268.
Andre, et al., “CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism”, Nat Med, Mar. 2002, vol. 8, pp. 247-252.
Baker, et al., “A Simple, Fluorescent Method to Internally Label Platelets Suitable for Physiological Measurements”, Am. J. Hem, Sep. 1997, vol. 56, pp. 17-25.
Berger, et al., “P-Selectin and platelet clearance”, Blood, Dec. 1998, vol. 92, pp. 4446-4452.
Bergmeier, et al., “Rhodocytin (aggretin) activates platelets lacking alpha2 beta1 integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha”, J. Biol. Chem. Jul. 2001, vol. 276, pp. 25121-25126.
Bergmeier, et al., “Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies”, Blood, 2000, vol. 95, pp. 886-893.
Berman, et al., “A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein”, J Clin Invest., 1986, vol. 78, pp. 130-137.
Berry, et al., “Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia”, Lancet, Oct. 1995, vol. 346, pp. 1073-1074.
Brown, et al., “Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase independent program”, J. Biol. Chem., Feb. 2000, vol. 275, pp. 5987-5995.
Corbi, et al., “The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B”, J. Biol. Chem., Sep. 1988, vol. 263, pp. 12403-12411.
Coxon, et al., “A novel role for the [beta]2 integrin CDI Ib/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation”, Immunity, Dec. 1996, vol. 5, pp. 653-666.
Denis, et al., “A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis”, Proc Natl Acad Sci U S A., Aug. 1998, vol. 95, pp. 9524-9529.
Dumont, et al., “Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)”, Transfus Med Rev, Jan. 1999, vol. 13, pp. 31-42.
Ellies, et al., “Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands”, PNAS, Jul. 2002, vol. 99, pp. 10042-10047.
Engelfriet, et al., “Bacterial contamination of blood components”. Vox Sang, 2000, vol. 78, pp. 59-67.
Greenberg & Jamieson, “The effects of various lectins on platelet aggregation and release”, Biochim. Biophys. Acta, Apr. 1974, vol. 345, pp. 231-242.
Hartwig, et al., “Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets”, Cell, 1995, vol. 82, pp. 643-653.
Hartwig & Desisto, “The cytoskeleton of the resting human blood platelet: Structure of the membrane skeleton and its attachment to actin filaments”, J. Cell Biol., Feb. 1991, vol. 112, pp. 407-425.
Hartwig, et al., “D3 phosphoinositides and outside-in integrin signaling by GPHb/IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate”, J. Biol. Chem., 1996, vol. 271, pp. 32986-32993.
Heilmann, et al., “Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets”, Cytometry, Dec. 1994, vol. 17, pp. 287-293.
Hoffmeister, et al., “Mechanisms of Cold-induced Platelet Actin Assembly”, J Biol Chem., 2001, vol. 276, pp. 24751-24759.
Jacobs, et al., “Don't bug me: the problem of bacterial contamination of blood components—challenges and solutions”, Transfusion, 2001, vol. 41, pp. 1331-1334.
Janmey & Stossel, “Gelsolin-polyphosphoinositide interaction. Full expression of gelsolin-inhibiting function by polyphosphoinositides in vesicular form and inactivation by dilution, aggregation, or masking of the inositol head group”, J. Biol. Chem., 1989, vol. 254, pp. 4825-4831.
Jaremo, et al., “Correlation of light transmission changes to changes of platelet glycoprotein Ib during storage of platelet concentrates”, Thromb Res, Mar. 1993, v
Clausen Henrik
Rosiello Keith
AGG Intellectual Property Law
Deak Leslie
Giugliano PC Antoinette G.
Marcetich Adam
Velico Medical, Inc.
LandOfFree
Apparatus for prolonging survival of platelets does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus for prolonging survival of platelets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus for prolonging survival of platelets will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287104